Role of Mxbp, a Transcription Factor, in Autoimmune

Ivashkiv, Lionel B.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 5K08AR001852-02
• Application #: 3079309
• Study Section: Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
• Project Start: 1991-01-01
• Project End: 1992-05-31
• Budget Start: 1992-01-01
• Budget End: 1992-05-31
• Support Year: 2
• Fiscal Year: 1992

Institution

• Name: Harvard University
• Type: Schools of Public Health
• DUNS #: 082359691
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02115

Publications

Ivashkiv, L B; Schmitt, E M; Castro, A (1996) Inhibition of transcription factor Stat1 activity in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway. J Immunol 157:1415-21

Wang, F; Sengupta, T K; Zhong, Z et al. (1995) Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. J Exp Med 182:1825-31

Ivashkiv, L B; Ayres, A; Glimcher, L H (1994) Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins. Immunopharmacology 27:67-77

Ivashkiv, L B; Fleming, M D; Glimcher, L H (1992) Dominant negative mutants of transcription factor mXBP (CRE-BP1, ATF-2). New Biol 4:360-8

Ivashkiv, L B; Glimcher, L H (1991) Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J Exp Med 174:1583-92